Aihe-ehdotuksia
Aihe-ehdotuksia
- Clinical trials
- Research
- Statistical methods
- Design 24
- Research Design 24
- statistics & numerical data 24
- Randomized Controlled Trials as Topic 20
- methods 20
- Adaptive sampling (Statistics) 16
- Clinical Trials as Topic 16
- Statistics as Topic 10
- Dose-Response Relationship, Drug 8
- Testing 7
- Antineoplastic Agents 6
- Antineoplastic agents 6
- Bayes Theorem 6
- Biometry 6
- Biostatistics 6
- Models, Statistical 6
- therapeutic use 6
- Bayesian statistical decision theory 4
- Biochemical markers 4
- Clinical Trials, Phase I as Topic 4
- Clinical Trials, Phase II as Topic 4
- Drug Dosage Calculations 4
- Drug-Related Side Effects and Adverse Reactions 4
- Evaluation 4
- Fraud 4
- Fraud in science 4
- Maximum Tolerated Dose 4
-
1
Surrogate endpoints, part 1 from definition to meta-analytic framework /
Julkaistu 2019Hae kokoteksti
Series
Elektroninen Video -
2
Phase II clinical trials traditional approaches /
Julkaistu 2018Hae kokoteksti
Series
Elektroninen Video -
3
-
4
-
5
Implementation of adaptive methods in early phase clinical trials
Julkaistu 2018Hae kokoteksti
Series
Elektroninen Video -
6
-
7
-
8
Bayesian adaptive designs for clinical trials
Julkaistu 2016Hae kokoteksti
Series
Elektroninen Video -
9
-
10
-
11
Biomarkers and surrogate endpoints in randomized clinical trials
Julkaistu 2016Hae kokoteksti
Series
Elektroninen Video -
12
Statistical methods to detect fraud and errors in clinical trials
Julkaistu 2016Hae kokoteksti
Series
Elektroninen Video -
13
-
14
Randomization in studies with unequal allocation
Julkaistu 2016Hae kokoteksti
Series
Elektroninen Video -
15
-
16
Statistics in regulatory science /
Julkaistu 2018Taylor & Francis
OCLC metadata license agreement
Elektroninen E-kirja -
17
Surrogate endpoints, part 1 from definition to meta-analytic framework /
Julkaistu 2019Hae kokoteksti
Series
Elektroninen Video -
18
Phase II clinical trials traditional approaches /
Julkaistu 2018Hae kokoteksti
Series
Elektroninen Video -
19
-
20
